InfuSystem Holdings, Inc
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $143.4M | $134.9M | $125.8M | $109.9M | $102.4M |
| Cost of revenue | $63.1M | $64.5M | $62.7M | $49.4M | $43.8M |
| Gross profit | $80.3M | $70.4M | $63.1M | $60.6M | $58.5M |
| Operating expenses | $68.4M | $63.5M | $59.0M | $58.9M | $55.7M |
| Operating income | $11.9M | $6.9M | $4.1M | $1.7M | $2.8M |
| Interest expense | $1.3M | $1.8M | $2.2M | $1.4M | $1.4M |
| Pretax income | $10.6M | $5.1M | $1.9M | $130,000 | $1.3M |
| Income tax expense | $4.0M | $2.7M | $979,000 | $112,000 | -$163,000 |
| Net income | $6.6M | $2.3M | $872,000 | $18,000 | $1.4M |
| Balance Sheet | |||||
| Cash and equivalents | $3.2M | $527,000 | $231,000 | $165,000 | $186,000 |
| Current assets | $36.3M | $32.2M | $30.6M | $24.8M | $22.1M |
| Total assets | $100.6M | $103.6M | $102.9M | $99.4M | $97.6M |
| Current liabilities | $20.2M | $17.7M | $15.7M | $14.5M | $12.9M |
| Total liabilities | $43.2M | $46.1M | $50.6M | $51.4M | $49.3M |
| Total debt | $20.0M | $24.1M | $29.4M | $33.4M | $33.4M |
| Stockholders' equity | $57.3M | $57.5M | $52.3M | $48.0M | $48.3M |
| Cash Flow Statement | |||||
| Cash from operations | $24.4M | $20.5M | $11.2M | $17.5M | $18.3M |
| Depreciation and amortization | $12.4M | $11.5M | $11.5M | $10.9M | $10.4M |
| Stock-based compensation | $4.4M | $4.5M | $4.1M | $3.8M | $6.4M |
| Capital expenditure | $560,000 | $1.1M | $1.0M | $982,000 | $980,000 |
| Free cash flow | $23.8M | $19.4M | $10.2M | $16.5M | $17.3M |
| Share repurchases | $9.9M | $1.2M | $153,000 | $5.5M | $560,000 |
Shares outstanding 20.2M · Free float 70.4%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.